BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17553050)

  • 1. Successful treatment of primary cutaneous follicle centre lymphoma with topical 5% imiquimod.
    Stavrakoglou A; Brown VL; Coutts I
    Br J Dermatol; 2007 Sep; 157(3):620-2. PubMed ID: 17553050
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical imiquimod therapy for cutaneous T-cell lymphoma.
    Do JH; McLaughlin SS; Gaspari AA
    Skinmed; 2003; 2(5):316-8. PubMed ID: 14673267
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara).
    Didona B; Benucci R; Amerio P; Canzona F; Rienzo O; Cavalieri R
    Br J Dermatol; 2004 Jun; 150(6):1198-201. PubMed ID: 15214911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical imiquimod as treatment for different kinds of cutaneous lymphoma.
    Coors EA; Schuler G; Von Den Driesch P
    Eur J Dermatol; 2006; 16(4):391-3. PubMed ID: 16935796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of stage IA cutaneous T-Cell lymphoma with topical application of the immune response modifier imiquimod.
    Suchin KR; Junkins-Hopkins JM; Rook AH
    Arch Dermatol; 2002 Sep; 138(9):1137-9. PubMed ID: 12224972
    [No Abstract]   [Full Text] [Related]  

  • 6. Imiquimod and the treatment of cutaneous T-cell proliferative diseases: at the threshold.
    Herbert WC
    Skinmed; 2003; 2(5):273-4. PubMed ID: 14673259
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple basal cell carcinomas after radiation treatment: successful treatment with topical imiquimod.
    Santiago Sánchez-Mateos D; Goiriz Valdés R; Daudén Tello E
    Clin Exp Dermatol; 2010 Mar; 35(2):199-200. PubMed ID: 19486047
    [No Abstract]   [Full Text] [Related]  

  • 8. Effective treatment of metastatic renal cell carcinoma with topical imiquimod therapy.
    Okino T; Fujioka A; Nakajima H; Tarutani M; Shuin T; Sano S
    J Dtsch Dermatol Ges; 2014 Feb; 12(2):155-7. PubMed ID: 24128072
    [No Abstract]   [Full Text] [Related]  

  • 9. Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up.
    Vidal D; Matías-Guiu X; Alomar A
    Arch Dermatol; 2007 Feb; 143(2):266-8. PubMed ID: 17310012
    [No Abstract]   [Full Text] [Related]  

  • 10. Regression of internal melanoma metastases following application of topical imiquimod to overlying skin.
    Miller AK; Dusing R; Meggison A; Aires D
    J Drugs Dermatol; 2011 Mar; 10(3):302-5. PubMed ID: 21369648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of primary extramammary Paget's disease of the perineum with topical imiquimod 5% cream.
    Dias Coelho J; Vale E; Viana I; Martins O
    Eur J Dermatol; 2010; 20(4):532-3. PubMed ID: 20566431
    [No Abstract]   [Full Text] [Related]  

  • 12. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.
    Urosevic M; Dummer R; Conrad C; Beyeler M; Laine E; Burg G; Gilliet M
    J Natl Cancer Inst; 2005 Aug; 97(15):1143-53. PubMed ID: 16077073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical imiquimod to treat recurrent breast cancer.
    Hengge UR; Roth S; Tannapfel A
    Breast Cancer Res Treat; 2005 Nov; 94(1):93-4. PubMed ID: 16172790
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple scrotal epidermolytic acanthomas successfully treated with topical imiquimod.
    Jang BS; Jang HS; Park HJ; Kim MB; Oh CK; Kwon KS
    J Dermatol; 2007 Apr; 34(4):267-9. PubMed ID: 17352727
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical imiquimod treatment of lentigo maligna: clinical and histologic evaluation.
    Kupfer-Bessaguet I; Guillet G; Misery L; Carre JL; Leroy JP; Sassolas B
    J Am Acad Dermatol; 2004 Oct; 51(4):635-9. PubMed ID: 15389205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome.
    Vereecken P; Monsieur E; Petein M; Heenen M
    J Dermatolog Treat; 2004 Apr; 15(2):120-1. PubMed ID: 15204165
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients.
    Tiodorovic-Zivkovic D; Zalaudek I; Longo C; De Pace B; Albertini G; Argenziano G
    Eur J Dermatol; 2012; 22(4):579-80. PubMed ID: 22652500
    [No Abstract]   [Full Text] [Related]  

  • 18. Hundreds of basal cell carcinomas in a Gorlin-Goltz syndrome patient cured with imiquimod 5% cream.
    Ferreres JR; Macaya A; Jucglà A; Muniesa C; Prats C; Peyrí J
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):877-8. PubMed ID: 16898919
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream.
    Ray CM; Kluk M; Grin CM; Grant-Kels JM
    Int J Dermatol; 2005 May; 44(5):428-34. PubMed ID: 15869545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Rub on' treatment for basal-cell carcinoma.
    Kerr C
    Lancet Oncol; 2002 Apr; 3(4):201. PubMed ID: 12067676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.